Judge: Teva not liable for Oxycontin patent violation

Share this article:

Generics and branded drugmaker Teva took a swing and won against painkiller company Purdue Pharma.

Bloomberg reports that Purdue, whose name is synonymous with Oxycontin, lost a legal battle in which it asserted that Teva's generic violated multiple patents.

US District Judge Sidney Stein agreed that Teva overstepped three patents, but said the “obvious” nature of the patents meant he was not going to hold the company liable.

Purdue told Bloomberg it will appeal the decision.

Share this article:

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.